Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.

CONCLUSION: High-quality evidence assessing conventional therapy in MS-IBD treatment is scarce, especially for remission maintenance, mucosal healing and fecal calprotectin.
PMID: 30863001 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - March 6, 2019 Category: Gastroenterology Authors: Damião AOMC, de Azevedo MFC, Carlos AS, Wada MY, Silva TVM, Feitosa FC Tags: World J Gastroenterol Source Type: research